Alimera Sciences Inc
General ticker "ALIM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $301.1M
Alimera Sciences Inc follows the US Stock Market performance with the rate: 36.6%.
Estimated limits based on current volatility of 0.5%: low 5.52$, high 5.57$
Factors to consider:
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.64$, 5.70$]
- 2024-12-30 to 2025-12-30 estimated range: [2.58$, 5.73$]
Financial Metrics affecting the ALIM estimates:
- Negative: Operating Income to Revenue ratio of -0.02 <= 0.01
- Negative: Non-GAAP EPS of -1.28 <= 0.11
- Negative: Operating Cash Flow per share of -0.56 <= 0.22
- Negative: negative Net Income
Short-term ALIM quotes
Long-term ALIM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $59.03MM | $54.13MM | $80.75MM |
| Operating Expenses | $59.23MM | $65.77MM | $82.22MM |
| Operating Income | $-0.20MM | $-11.64MM | $-1.47MM |
| Non-Operating Income | $-3.73MM | $-6.44MM | $-18.58MM |
| Interest Expense | $5.41MM | $5.88MM | $10.19MM |
| R&D Expense | $13.78MM | $16.23MM | $16.63MM |
| Income(Loss) | $-3.93MM | $-18.08MM | $-20.05MM |
| Taxes | $0.44MM | $0.03MM | $0.09MM |
| Profit(Loss) | $-4.37MM | $-18.11MM | $-20.13MM |
| Stockholders Equity | $-2.60MM | $-20.85MM | $46.17MM |
| Assets | $58.52MM | $42.60MM | $153.52MM |
| Operating Cash Flow | $-3.22MM | $-9.97MM | $-14.26MM |
| Investing Cash Flow | $-0.62MM | $-0.26MM | $-75.53MM |
| Financing Cash Flow | $9.82MM | $-0.30MM | $96.50MM |
| Earnings Per Share* | $-0.66 | $-2.59 | $-0.79 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.